Los Angeles, April 11 (IANS) Two people were killed and four others injured in a shooting in Los Angeles, local authorities said.
The shooting occurred at 4.13 p.m. on Sunday evening in the US city's 12200 block of Blakley Avenue, Xinhua news agency quoted the Los Angeles County Sheriff's Department as saying in a notification.
Two male adult victims were pronounced dead at the scene, the Department said.
An additional four gun-shot victims were transported to nearby hospitals and their conditions remained unknown as of Monday morning, it added.
"There is no additional information available at this time," the Department said, urging anyone with information about the incident to contact its Homicide Bureau.
British Prime Minister Boris Johnson has shot down speculation that the UK will ease immigration rules for India as part of a Free Trade Agreement (FTA). Negotiations on an Indo-British FTA are scheduled to begin this month.
While Omicron does appear to be less severe compared to Delta, especially in those vaccinated, it does not mean it should be categorised as 'mild' as just like previous variants, Omicron is hospitalising people and it is killing people, WHO Director-General Dr Tedros Adhanom Ghebreyesus said on Thursday.
The president of the United States called out predecessor Donald Trump not by name but by reputation Thursday, marking one year since the Capitol Hill riots with a remarkably simple exhortation to his fellow Americans: to tell and spread and embrace the truth about the 2020 election.
Thursday marks one year since frenzied supporters of Donald Trump, spurred on by the outgoing president's bogus claims of a stolen election, laid siege to the U.S. Capitol in what's now widely seen as an organized effort to prevent Joe Biden from taking over as commander-in-chief.
Eleanor Taylor of the group Aman Lara, an organization that helps Afghans get out of the country, said the little girl named Nafiza was shot and killed while the family was travelling back from a wedding late in the evening of Dec. 10.
The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms.
